Your session is about to expire
← Back to Search
Afimoxifene for Mammographically Dense Breast
Study Summary
This trial looks at how well a drug called afimoxifene reduces the risk of breast cancer in women with dense breasts. The drug works by blocking the effects of estrogen.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 194 Patients • NCT03063619Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You must not tan your breast skin using natural or artificial sunlight during the study.
- Group 1: Arm A (placebo)
- Group 2: Arm B (afimoxifene)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it possible to join this clinical trial at this time?
"Unfortunately, this particular study has wrapped up recruitment. First appearing on May 1st, 2017 and last updated on August 12th, 2022, the trial is no longer looking for participants. However, there are currently 1 breast cancer trials and 3 Afimoxifene trials that are actively recruiting patients."
How many people are being enrolled in this clinical trial?
"At the moment, this particular clinical trial is not seeking any new participants. The last update to this study was on August 12th, 20212 and it was originally posted on May 1st, 2017. There are currently one study for breast cancer and three studies involving Afimoxifene that are actively recruiting patients."
Has Afimoxifene been cleared for use in the United States?
"While Phase 2 trials don't have the same data supporting efficacy, there is evidence that Afimoxifene is safe. For this reason, Power gave it a score of 2."
Could I join this experiment if I meet the requirements?
"To be eligible for this study, patients must have breast cancer and fall in the age range of 40 to 69. At present, there are 152 people that meet these criteria enrolled in the trial."
In how many different hospitals is this clinical trial being run today?
"The clinical trial is currently running at five locations: Dana-Farber Cancer Institute in Boston, Columbia University/Herbert Irving Cancer Center in New york, Northwestern University in Chicago, and other locations."
Is Afimoxifene a common drug in medical research?
"Afimoxifene was first trialled in 2016 at Kantonsspital Aarau. Since then, it has undergone 18952 completed clinical trials. Currently, there are 3 ongoing Afimoxifene trials with a majority of them taking place in Boston, Massachusetts."
Will elderly patients be rejected from this experiment?
"The age limit for patients hoping to enroll in this study is 69 years old. The minimum age requirement is 40 years old."
Share this study with friends
Copy Link
Messenger